Nuclear molecular imaging is a popular research tool across multiple preclinical applications including oncology, neurology, and cardiology. Todd Sasser at Bruker BioSpin explains how it enables researchers to access functional, structural and metabolic information to study disease and therapeutics in preclinical models and is used widely in clinical diagnostics.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/11/Multi-modal-Positron-Emission-Tomography-PET.pdf” width=”100%” height=”900px” style=”border:0;”]